Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Pressure BioSciences Inc. (PBIO) is “On Alert”

Pressure BioSciences Inc. is a life sciences company we have followed for much of this year through our relationship with the Red Chip Conferences. Pressure BioSciences, Inc. shares were hit with an inexplicable sell off this week, which has many speculating the sell off could be due impart to investor confusion linking Pressure BioSciences, Inc. and Panacos Pharmaceuticals Inc. which neared its 52 week low after disappointing results from Panacos HIV drug candidate bevirimat. Pressure BioSciences Inc. did initially have a passive investment in Panacos Pharmaceuticals, but sold off all of its interest in the investment over six month ago, as an opportunity to strengthen its cash position. The unexpected drop in price may give investors a chance to jump on (PBIO) shares at a reduced price.

Pressure BioSciences Inc. continues to make advancements regarding its pressure cycling technology (PCT). Frost & Sullivan announced that Pressure BioSciences, Inc. has been named the recipient of the 2007 North American Frost & Sullivan Award for Technology Innovation. The award is in recognition of the development and advancements regarding the combination of the Company’s Pressure Cycling Technology (PCT) with the innovative chemistry of its ProteoSolve-LRS kit. The breakthrough is significant because it streamlines and improves upon the complex process of development of a method for the detergent-free extraction of proteins from lipid rich tissues, resulting in higher protein recovery, enhanced reproducibility, and significant advantages in speed and handling.

Frost & Sullivan Senior Research Analyst Sandhya Kamath stated in the report “Protein expression from lipid rich tissues is crucial to understanding many disease states such as obesity, heart disease, diabetes, and certain cancer types, among others.” “As a result, sample preparation is drawing attention in proteomic studies since it can affect the accuracy and the overall quality of the downstream analytical processes.”

Pressure BioSciences Inc. recently presented its study which is focused on the discovery and identification of potential bio markers of colon cancer that used pressure cycling technology (PCT) for the extraction of proteins from colon cancer tissues bio markers. The purpose of this study was to identify proteins in tissue samples from patients with colon cancer that might be reliable bio markers for this disease. In the past identifying patients with this disease who have been shown to benefit from therapy is difficult due to the lack of reliable bio markers.

Let us hear your thoughts: Pressure BioSciences, Inc. Message Board

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *